Literature DB >> 2285595

Growth factor expression in breast tissue.

R C Coombes1, P Barrett-Lee, Y Luqmani.   

Abstract

We have studied mRNA levels for a variety of growth factors in biopsy specimens from malignant, benign and normal breast tissue. We found TGFb mRNA in all breast cancers and neoplastic breast tissues but the level of the TGFb mRNA were found to be higher in breast cancer (P = 0.01). TGFa mRNA was detected in a similar proportion of cancers as in neoplastic breast tissues but the TGFa receptor EGFR mRNA was detected in only 55% of breast cancers but in all non-neoplastic breast tissue tested. The presence of EGFR mRNA was inverted related to oestrogen receptor status and coexpression of TGFa and EGFR was observed in 28% of carcinomas, and significantly more commonly in ER negative tumours (P = 0.01). PDGF a and b chain transcripts coexisted in all normal and malignant breast tissue. Insulin-like growth factor II mRNA was present in all 15 samples of non-malignant breast tissue but in only 11 of 21 (52%) of carcinomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285595     DOI: 10.1016/0960-0760(90)90428-n

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  The prognostic significance of epidermal growth factor receptor expression in breast cancer.

Authors:  M Noguchi; Y Mizukami; K Kinoshita; M Earashi; M Thomas; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study.

Authors:  P G Koenders; L V Beex; C B Kienhuis; P W Kloppenborg; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  The effects of retinoid status on TGF beta expression during mouse embryogenesis.

Authors:  R Mahmood; K C Flanders; G M Morriss-Kay
Journal:  Anat Embryol (Berl)       Date:  1995-07

4.  β-Catenin is required for Ron receptor-induced mammary tumorigenesis.

Authors:  P K Wagh; J K Gray; G M Zinser; J Vasiliauskas; L James; S P Monga; S E Waltz
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

5.  Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.

Authors:  I E Eder; A Stenzl; A Hobisch; M V Cronauer; G Bartsch; H Klocker
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer.

Authors:  J C Newby; R P A'Hern; R D Leek; I E Smith; A L Harris; M Dowsett
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

7.  Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.

Authors:  L M Coombs; D A Pigott; M E Eydmann; A J Proctor; M A Knowles
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.